Navigation Links
WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results
Date:3/12/2008

Full Year Net Revenues up 93.3%; Full Year Net Income up 283.0%

SHANGHAI, China, March 12 /Xinhua-PRNewswire-FirstCall/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), the leading global pharmaceutical, biotechnology and medical device R&D outsourcing company headquartered in Shanghai, China, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2007.

Fourth Quarter 2007 Highlights:

Compared to the fourth quarter 2006 results,

-- Total net revenues increased 62.4% to $37.1 million.

-- Net income increased 205.7% to $12.1 million.

-- Non-GAAP net income increased 156.7% to $16.6 million.

-- Diluted earnings per American Depositary Share ("ADS") were $0.17.

Diluted earnings per ADS excluding share-based compensation expenses

(non-GAAP) were $0.23.

Full Year 2007 Highlights:

Compared to full year 2006 results,

-- Total net revenues increased 93.3% to $135.2 million.

-- Net income increased 283.0% to $33.9 million.

-- Non-GAAP net income increased 158.5% to $44.6 million.

-- Diluted earnings per ADS were $0.42. Diluted earnings per ADS

excluding share-based compensation expenses (non-GAAP) were $0.59.

Commenting on the fourth quarter and full year results, Dr. Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech said, "2007 was an historic year for WuXi, marked by a number of key strategic and tactical milestones. Riding on the rising wave of demand for pharmaceutical and biotechnology R&D outsourcing services, our business experienced phenomenal growth, with revenues for the year at $135 million, up 93% from 2006, attributable to a strong performance across both
'/>"/>

SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. WuXi PharmaTech Schedules Fourth Quarter and Full Year 2007 Earnings Release on Wednesday, March 12, 2008
2. WuXi PharmaTech Completes Acquisition of AppTec
3. Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer
4. WuXi PharmaTech (NYSE: WX) CEO Honored among the 2007 China Top 10 Influential Entrepreneurs
5. WuXi PharmaTech to Acquire AppTec Laboratory Services, Inc.
6. WuXi PharmaTech (NYSE: WX) Promotes Edward Hu to COO
7. Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology
8. Massachusetts Governor Deval L. Patrick Pays Visit to WuXi PharmaTech
9. WuXi PharmaTech (NYSE: WX) Ranked the 28th of Deloitte Technology Fast 50 China
10. WuXi PharmaTech (NYSE: WX) Wins Both Deloitte Technology Fast 50 China and Deloitte Technology Fast 500 Asia
11. WuXi PharmaTech Announces Second Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... July 24, 2014 Three companies from ... in Livestrong’s Big C Competition. Out of 700 competition ... headed to the semi-final round. In this round twenty ... accelerator program, complete with mentoring from thought-leaders and medical ... part of the angelMD commitment to the Livestrong vision ...
(Date:7/24/2014)... The first part of the session on “Best ... Studies” will cover comprehensive clinical support in early phase ... R&D costs and declining industry success in getting products ... collected in early Phase I/IIa study data to make ... development. , Next, the presenters will examine steps to ...
(Date:7/24/2014)... CA (PRWEB) July 24, 2014 ... reporting of molecular diagnostic test results. It also ... necessary for the validation and reporting of high ... Molecular diagnostics is a rapidly growing area of ... disease, genetic predisposition, cancer, and companion diagnostics in ...
(Date:7/23/2014)... Filippov (MIPT and Russian Quantum Center at Skolkovo) ... Republic, and the Institute of Physics in Bratislava, ... entanglement of particles passing through an amplifier and, ... Details are provided in an article published in ... preprint). , Quantum entangled particles are considered to ...
Breaking Biology Technology:3 angelMD Startups Make Livestrong Big C Semi-finals 2Best Practices for Optimizing Dose Escalation in First in Human Studies, New Webinar August 6th Hosted by Xtalks 2New DNA-barcode Patent Virtually Eliminates False Test Results and Sample Mix-up 2Scientists find way to maintain quantum entanglement in amplified signals 2Scientists find way to maintain quantum entanglement in amplified signals 3Scientists find way to maintain quantum entanglement in amplified signals 4
... Therapeutics (NYSE Amex: CXM ) today reported that the Company has received a letter ... the Company,s exchange listing compliance. , , , ... , , ... , , In the ...
... ... come when sorghum, sugar cane and other crops are considered , ... (PRWEB) July 7, 2010 -- Banning the agricultural ... to University of Chicago economist Don L. Coursey, Ph.D . , , ,Dr. Coursey ...
... July 7 DATATRAK International, Inc. (OTCQX: DATA), a ... the clinical trials industry, today announced that it privately placed ... per share with certain members of its Board of ... the private placement are restricted securities and are subject to ...
Cached Biology Technology:Cardium Regains Listing Compliance With NYSE Amex 2Cardium Regains Listing Compliance With NYSE Amex 3Cardium Regains Listing Compliance With NYSE Amex 4Loss of Atrazine Would Wipe Out 21,000 to 48,000 Jobs Dependant on Agriculture 2Loss of Atrazine Would Wipe Out 21,000 to 48,000 Jobs Dependant on Agriculture 3DATATRAK Completes Sale of 357,857 Common Shares to Directors and Management 2DATATRAK Completes Sale of 357,857 Common Shares to Directors and Management 3
(Date:7/24/2014)... of the primordial soup in which life arose have been ... University of East Anglia. , Research published today in the ... plants, yeast and very likely also in animals still perform ... of life some four billion years ago. , The ... or ocean as a result of the combination of metals, ...
(Date:7/24/2014)... available in German . ... million asthma sufferers worldwide, a further 600 million people ... the global population contending with allergic rhinitis (allergic inflammation ... affect other organs and parts of the body beyond ... (in the form of inflammatory bowel diseases such as ...
(Date:7/24/2014)... eye doctors and scientists from Singapore have developed Asia,s ... of eye disease that affects the cornea called corneal ... of vision. , Called the POLARIS TGFBI (Transforming ... designed to aid in the diagnosis and management of ... family members carrying a TGFBI mutation who may also ...
Breaking Biology News(10 mins):New drugs to combat asthma and the like 2New drugs to combat asthma and the like 3Singapore team develops Asia's first genetic test that can prevent corneal blindness 2Singapore team develops Asia's first genetic test that can prevent corneal blindness 3
... popular forage and turf grass called tall fescue covers a vast ... to be larger than Virginia and Maryland combined -- and a ... there is more to fescue than meets the eye. Results ... Journal of Applied Ecology , show that a symbiotic fungus living ...
... fertilized egg cell. Following numerous cell divisions, it then ... tissues. The largely unexplained process whereby the cells simply ... is an astonishing phenomenon. Scientists from the Center for ... and the University of Wageningen, in cooperation with colleagues ...
... From cutting-edge photovoltaic power generation systems to substrates ... materials are playing an expanding role in the world,s ... Ceramic Society (ACerS) today launched a major peer-reviewed journal ... of Applied Glass Science ( IJAGS ). ...
Cached Biology News:Study: Grass, fungus combination affects ecology 2How plants put down roots 2Ceramic society launches new glass science and applications journal 2
... provides complete components including positive and ... of DNA fragmentation in cultured cells ... BrdU in the procedure provides greater ... Results can be analyzed by fluorescence ...
... LAS-3000 imaging system combines new CCD ... interface, providing significantly improved system sensitivity ... The system is especially dedicated to ... system for Western blotting applications.,Fuiji's LAS-3000 ...
... The Fujifilm Life Science LAS-3000mini is ... dedicated to chemiluminescence applications, and the ... applications., Fuiji 's LAS-3000 provides significantly ... digitization. , Glowell calibration standards validate ...
... 50 assays. The TUNEL-based assay kit provides ... cells for convenient detection of DNA fragmentation ... assay offers an one-step labeling of apoptotic ... a hallmark of apoptosis in mammalian cells. ...
Biology Products: